OncoImmune machine-learning model predicts immune response and prognosis in leiomyosarcoma. Biomol Biomed [Internet]. 2025 Jun. 4 [cited 2025 Nov. 17];25(10):2308–2323. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/12342